NUVL
Nuvalent, Inc.
NASDAQ · USHealthcareBiotechnology
$123.96+0.00%
Price as of Jul 14, 2026
NUVL valuation
Nuvalent, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 66.72x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.34x
- Price / sales
- —
- Price / cash flow
- -31.31x
Enterprise value
- Enterprise value
- $8.5B
- EV / sales
- —
- EV / EBITDA
- -25.44x
- EV / EBIT
- -19.38x
- Market cap
- $9.8B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.